Shubhangi Shelke 
Introduction : In today’s healthcare system, pharmacy inventory management plays a critical role in ensuring that medicines are available, safe and cost-effective. A well-managed inventory not only supports patient care but also increases profits, prevents waste and reduces stock-related errors. By integrating modern techniques such as FIFO, ABC analysis and EOQ models, pharmacies can gain …
Introduction : Managing diabetes can be expensive, especially when you’re dealing with test strips, lancets, and glucometers. But here’s the good news: In 2025, several trusted programs and brands are offering free glucometers and strips to eligible individuals. Whether you’re newly diagnosed or have been managing diabetes for a long time, you can still get …
Introduction : Taurolidine is a broad-spectrum antimicrobial agent that is gaining attention for its role in preventing catheter-associated infections. Approved by the US FDA on November 15, 2023, as part of the combination product Defencath (taurolidine and heparin), this compound has shown promising results in reducing infections associated with central venous catheters (CVCs). Catheter-associated bloodstream …
Introduction : On April 11, 2025, the U.S. Food and Drug Administration approved the combination of Opdivo and Yervoy as a first-line treatment for adults with unresectable or metastatic hepatocellular carcinoma (HCC), the most common form of liver cancer. This approval is a major advance in immunotherapy, especially for patients who previously had limited treatment …
Introduction to Berdazimer Gel : What Is Berdazimer ? Berdazimer is a topical medication that was approved by the US FDA in 2024 for the treatment of molluscum contagiosum in patients 1 year of age and older. It is formulated at a 10.3% strength and is the first nitric oxide-releasing gel of its kind for …
Introduction : Hereditary angioedema (HAE) is a rare and potentially life-threatening genetic condition characterized by sudden swelling in various parts of the body. Managing acute attacks has long been a challenge, but a new FDA-approved oral treatment is offering hope. Acterly, the first-of-its-kind oral plasma kallikrein inhibitor, is revolutionizing the way patients are treated for …
Introduction : Urinary tract infections (UTIs) are the most common bacterial infections in women. With increasing antibiotic resistance, the medical community urgently needs new, more effective agents. In a major breakthrough, the US FDA approved Blujepa in March 2025 for the treatment of uncomplicated urinary tract infections (uUTIs) in female patients aged 12 years and …
Generic Name : Nipocalimab Brand Name : Imaavy Drug Class : Anti-neonatal Fc receptor (FcRn) monoclonal antibody Dosage form : Injection . Introduction : Autoimmune diseases have long presented challenges in treatment and management. One such condition is myasthenia gravis (MG), a chronic autoimmune neuromuscular disorder that causes weakness in skeletal muscles. In 2024, a …
Brand Name : Vanrafia Generic Name : atrasentan Drug Class : endothelial antagonist Dosage Form : Oral tablets . Introduction : Having too much protein in your urine isn’t just a symptom—it’s a red flag that indicates kidney damage. If left unchecked, proteinuria can lead to chronic kidney disease (CKD) and even end-stage renal failure. …
Brand name: QfitliaGeneric name: fitusiranDosage form: InjectionDrug class : Antithrombin-targeting siRNA Introduction : In March 2025, a historic breakthrough was made in the world of rare diseases – the US FDA officially approved Fitusiran approval for the treatment of hemophilia A and B, with and without inhibitors. The approval was long-awaited due to the drug’s revolutionary RNA interference …
